Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Clofarabine Action Pathway
Homo sapiens
Drug Action Pathway
Clofarabine is a purine (adenosine) antimetabolite, it is a drug used as an antineoplastic in the treatment of pediatric patients with relapsed or refractory acute lymphocytic leukemia. This molecule differs from the other purine analogs by chlorine in the purine ring and fluorine in the ribose moiety. This drug enters the cell and is metabolized to the active 5'-monophosphate metabolite by the enzyme deoxycytidine kinase. It is also metabolized in the 5'-triphosphate metabolite by mono- and di-phospho kinase. The tri-phosphate metabolite inhibits DNA synthesis through an inhibitory action on ribonucleotide reductase, and by terminating DNA elongation and inhibiting repair through competitive inhibition of DNA polymerases. Those inhibitions lead to the depletion of the intracellular deoxynucleotide triphosphate pool thereby intensifying the effectiveness of DNA synthesis inhibition. Clofarabine 5'-triphosphate also disrupts the integrity of the mitochondrial membrane, leading to the release of the pro-apoptotic mitochondrial proteins, cytochrome C, and apoptosis-inducing factor. All of the cited inhibitions and activities of this drug lead to cell death (apoptosis). This drug is administered as an intravenous injection.
References
Clofarabine Pathway References
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
Pubmed: 29126136
Pession A, Masetti R, Kleinschmidt K, Martoni A: Use of clofarabine for acute childhood leukemia. Biologics. 2010 Jun 24;4:111-8. doi: 10.2147/btt.s10123.
Pubmed: 20631817
Harned TM, Gaynon PS: Treating refractory leukemias in childhood, role of clofarabine. Ther Clin Risk Manag. 2008 Apr;4(2):327-36. doi: 10.2147/tcrm.s2941.
Pubmed: 18728851
Larson ML, Venugopal P: Clofarabine: a new treatment option for patients with acute myeloid leukemia. Expert Opin Pharmacother. 2009 Jun;10(8):1353-7. doi: 10.1517/14656560902997990.
Pubmed: 19463072
Zhenchuk A, Lotfi K, Juliusson G, Albertioni F: Mechanisms of anti-cancer action and pharmacology of clofarabine. Biochem Pharmacol. 2009 Dec 1;78(11):1351-9. doi: 10.1016/j.bcp.2009.06.094. Epub 2009 Jul 1.
Pubmed: 19576186
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings